This article was originally published in The Gray Sheet
Stent for treatment of small coronary vessels will debut in U.S. later this month in diameters of 2.0 mm, 2.25 mm and 2.5 mm. FDA approval via PMA supplement, announced July 9, allows use for abrupt or threatened closure due to unsuccessful interventional therapy in de novo and restenotic native coronary artery lesions. Device was launched in Europe earlier this year
You may also be interested in...
Guidant expects FDA approval of its next-generation Pixel stent for small vessels within the coming weeks
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.